Kingchem Lifesciences — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

A Chinese biotech developing novel small molecule drugs for oncology and metabolic disorders.

OncologyMetabolic Diseases

Utilizes structure-based drug design and high-throughput screening platforms to discover and optimize novel small molecule therapeutics.

Potential to address large patient populations in China with first-in-class or best-in-class targeted therapies.

High risk of clinical failure and significant capital requirements to advance pipeline through development stages.

Faces intense competition from numerous Chinese and global biotechs also pursuing novel small molecules in similar therapeutic areas.